The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Thoracic Cancer
(Feb 2022)
Optimal duration of adjuvant bisphosphonate treatment for high‐risk early breast cancer: Results from a SUCCESS trial
Mingbei Lu,
Beibei Ren,
Lingyan Rao
Affiliations
Mingbei Lu
Department of Thyroid and Breast Surgery Lishui People's Hospital Lishui China
Beibei Ren
Department of Thyroid and Breast Surgery Lishui People's Hospital Lishui China
Lingyan Rao
Department of Thyroid and Breast Surgery Lishui People's Hospital Lishui China
DOI
https://doi.org/10.1111/1759-7714.14257
Journal volume & issue
Vol. 13, no. 3
pp. 519 – 520
Abstract
Read online
No abstracts available.
Keywords
adjuvant bisphosphonate treatment
breast cancer
SUCCESS A trial
treatment duration
WeChat QR code
Close
